[3H]LY341495, a highly potent, selective and novel radioligand for labeling group II metabotropic glutamate receptors

被引：40
|
作者：
Ornstein, PL [1 ]
Arnold, MB [1 ]
Bleisch, TJ [1 ]
Wright, RA [1 ]
Wheeler, WJ [1 ]
Schoepp, DD [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 14期
关键词：
D O I：
10.1016/S0960-894X(98)00329-1
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report herein the synthesis and pharmacological characterization of a tritiated version of the potent and selective cyclopropyl amino acid LY341495 as a radioligand to label group II metabotropic glutamate receptors in rat brain homogenates. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1919 / 1922
页数：4
相关论文
共 50 条
  • [41] Opposite effects of Zn on the in vitro binding of [3H]LY354740 to recombinant and native metabotropic glutamate 2 and 3 receptors
    Malherbe, P
    Richards, JG
    Broger, C
    Zenner, MT
    Messer, J
    Kratzeisen, C
    Nakanishi, S
    Mutel, V
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 94 (01) : 150 - 160
  • [42] A novel binding assay for metabotropic glutamate receptors using [3H] L-quisqualic acid and recombinant receptors
    Ohashi, H
    Maruyama, T
    Higashi-Matsumoto, H
    Nomoto, T
    Nishimura, S
    Takeuchi, Y
    [J]. ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 2002, 57 (3-4): : 348 - 355
  • [43] LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia
    Bond, A
    Ragumoorthy, N
    Monn, JA
    Hicks, CA
    Ward, MA
    Lodge, D
    O'Neill, MJ
    [J]. NEUROSCIENCE LETTERS, 1999, 273 (03) : 191 - 194
  • [44] Xanthurenic Acid as a Novel Putative Agonist of Group II Metabotropic Glutamate Receptors
    Fazio, F.
    Molinaro, G.
    Iacovelli, L.
    Bernabucci, M.
    Mauro, G.
    Di Menna, L.
    Notartomaso, S.
    Zappulla, C.
    D'Amore, V.
    Battaglia, G.
    Nicoletti, F.
    Bruno, V.
    Di Marco, R.
    [J]. CURRENT NEUROPHARMACOLOGY, 2011, 9 : 19 - 19
  • [45] CHARACTERIZATION OF BLADDER MUSCARINIC RECEPTORS BY A NOVEL RADIOLIGAND, [3H]IMIDAFENACIN
    Kuraoka, S.
    Xuan, H.
    Ito, Y.
    Yamada, S.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2012, 31 (06) : 892 - 894
  • [46] The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268
    Imre, Gabor
    [J]. CNS DRUG REVIEWS, 2007, 13 (04): : 444 - 464
  • [47] Design and synthesis of novel molecular probes for metabotropic glutamate receptors (mGLURs). Discovery of LY354740 monohydrate: A potent, selective and systemically active group 2 mGLUR agonist
    Monn, JA
    Valli, MJ
    Goldsworthy, J
    Baker, SR
    Howe, T
    Pedregal, C
    Wright, RA
    Salhoff, CR
    Johnson, BG
    Tizzano, JP
    Helton, DR
    Kallman, MJ
    Schoepp, DD
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 104 - MEDI
  • [48] [3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy:: Potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor
    Cosford, NDP
    Roppe, J
    Tehrani, L
    Schweiger, EJ
    Seiders, TJ
    Chaudary, A
    Rao, S
    Varney, MA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 351 - 354
  • [49] Neuroprotective actions of novel and potent ligands of group II metabotropic glutamate receptors: Differentiation of effects on apoptotic versus necrotic neurons
    Kingston, AE
    O'Neill, MJ
    Bond, A
    Monn, JA
    Lodge, D
    Schoepp, DD
    [J]. NEUROPHARMACOLOGY, 1999, 38 (10) : A23 - A23
  • [50] In vitro and in vivo pharmacological profile of MGS0039, a novel potent and selective antagonist of group II metabotropic glutamate receptor
    Yoshikawa, R
    Okuno, S
    Shimazaki, T
    Yasuhara, A
    Okuyama, S
    Nakazato, A
    Nakanishi, S
    Chaki, S
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 165P - 165P
12345